OSS ORTHOPAEDIC HOSPITAL
1. Target Overview & Investment Thesis
OSS ORTHOPAEDIC HOSPITAL is a 30-bed community hospital in YORK, PA with $149.4M in net patient revenue and a -5.0% operating margin. The hospital serves a payer mix of 38.9% Medicare, 0.0% Medicaid, and 61.1% commercial.
Thesis: Turnaround. Our ML models identify $11.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.0% to 2.4% (+736bps).
| Net Revenue HCRIS | $149.4M |
| Current EBITDA COMPUTED | $-7.5M |
| Operating Margin COMPUTED | -5.0% |
| Occupancy HCRIS | 20.8% |
| Revenue / Bed COMPUTED | $5.0M |
| Net-to-Gross HCRIS | 31.2% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -5.0% places it below the state median. Among 68 size-comparable peers (15-60 beds), the median margin is -0.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (15-60), prioritizing same-state peers. 68 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| OSS ORTHOPAEDIC HOSPITAL (Target) | PA | 30 | $149.4M | -5.0% |
| WELLSPAN SURGERY AND REHAB HOS | PA | 25 | $120.2M | 2.8% |
| UPMC LITITZ | PA | 36 | $114.5M | 14.2% |
| MINERS MEMORIAL MEDICAL CENTER | PA | 49 | $107.7M | 12.4% |
| LVH-COORDINATED ALLENTOWN | PA | 20 | $89.6M | 2.3% |
| CHARLES COLE MEMORIAL HOSPITAL | PA | 25 | $88.1M | -9.0% |
| ST LUKES HOSPITAL-CARBON CAMPU | PA | 52 | $86.4M | 8.1% |
| POCONO MEDICAL CENTER DICKSON | PA | 40 | $85.9M | 0.1% |
| WELLSBORO | PA | 25 | $85.6M | 2.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $96K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-7.5M |
| + RCM Uplift | +$11.0M |
| Pro Forma EBITDA | $3.5M |
| Current Margin | -5.0% |
| Pro Forma Margin | 2.4% |
| WC Released (1x) | $5.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-11.5M | $60.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-11.5M | $63.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-10.3M | $95.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-10.3M | $101.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-12.6M | $9.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-12.6M | $6.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 20.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 68 hospitals with 15-60 beds
- Same-state prioritization (n=69)
- Comp margins: P25=-16.1% / P50=-0.1% / P75=8.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.